Research programme: hetero biarylpyridoquinazolinone analogues - Wyeth
Alternative Names: Anticancer agents research programme - WyethLatest Information Update: 03 Oct 2011
At a glance
- Originator Wyeth
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 04 May 2000 Preclinical development for Cancer in USA (Unknown route)